ConductScience.org, home

Gene · 7532

YWHAG: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. YWHAG: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma. Genes, record 7532. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7532

On this page

Gene

Symbol
YWHAG
HGNC
Name
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma
HGNC
NCBI Gene ID
7532
NCBI Gene
HGNC ID
HGNC:12852
HGNC
Ensembl
ENSG00000170027
NCBI Gene
Aliases
14-3-3GAMMA, 14-3-3γ, DEE56, EIEE56, PPP1R170
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P6198114-3-3 protein gamma24722Ensembl, GeneID, HGNC

Source UniProt

Patents85

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4805736 A22026-09-164P61981Espacenet
JP 2026004568 A2026-01-1468777P61981Espacenet
EP 4650780 A22025-11-194412P61981Espacenet
EP 4641202 A22025-10-294809P61981Espacenet
JP 2025517970 A2025-06-124412P61981Espacenet
US 12275779 B22025-04-1534P61981Espacenet
KR 1020250017231 A2025-02-044809P61981Espacenet
US 11708396 B22023-07-251324P61981Espacenet
US 11446398 B22022-09-2094255P61981Espacenet
JP 2022524081 A2022-04-27197226P61981Espacenet

1 to 10 of 85

See all 85 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants975

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleYWHAG papersNewest fiscal year
P30CA016672Cancer Center Support Grant72025
P30CA008748Cancer Center Support Grant62025
P30CA023074University of Arizona Cancer Center - Cancer Center Support Grant62025
T32CA009054A Training Program for Interdisciplinary Cancer Research42025
P01AG026276Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study32025
P30AG066444Alzheimer's Disease Research Center32025
P30CA021765Cancer Center Support Grant (CCSG)32025
P30CA062203Cancer Center Support Grant32025
P30CA068485Cancer Center Support Grant32025
P01CA120964Molecular Pathogenesis of the Hamartoma Syndromes22025

1 to 10 of 975Source NIH's project files

See all 975 nih grants

Papers1,458

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
YWHAG overexpression correlates with an immune-desert microenvironment and poor prognosis in laryngeal squamous cell carcinoma.Front Immunol202642812507PubTator, text miningPubMed
Transient ultrastructural remodeling of the open canalicular system and α-granules is associated with endothelial responses after BNT162b2 vaccination in healthy volunteers.Biomed Pharmacother202642809927PubTator, text miningPubMed
Identification of Inflammatory Cell Death-Related Prognostic Signature and Its Regulatory Mechanism in Lung Adenocarcinoma.Cancer Med202642760759PubTator, text miningPubMed
Stratifying lung adenocarcinoma: a novel prognostic model based on mitochondrial outer membrane permeabilization activity.3 Biotech202642745950PubTator, text miningPubMed
Isoform-resolved 14-3-3/YWHA networks in colorectal cancer: phospho-adaptor mechanisms, biomarker contexts and therapeutic opportunities.Front Oncol202642688965PubTator, text miningPubMed
Integrated PANoptosis Profiling Identifies Immunosuppressive Subtypes and a Prognostic Signature With Functional Validation of MLKL in Glioblastoma.Ann Clin Transl Neurol202642421178PubTator, text miningPubMed
Decoding The Epitranscriptome: In Silico Insights Into m6A Regulatory Network In Breast Cancer.J Vis Exp202642372047PubTator, text miningPubMed
Beyond amyloid and tau: synaptic and neurodegenerative biomarkers shape MCI progression.Mol Psychiatry202642337011PubTator, text miningPubMed
A P-body-related risk score predicts prognosis and immune microenvironment in lung adenocarcinoma.Transl Cancer Res202642305460PubTator, text miningPubMed
From prediction to mechanism: Explainable AI uncovers plasma and CSF proteomic signatures of Alzheimer's disease.J Proteomics202642297098PubTator, text miningPubMed

1 to 10 of 1,458

See all 1,458 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/7532

GET https://conductscience.org/api/genes/v1/7532/patents?page=2